Quantum BioPharma Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QNTM research report →
Price Chart
About the company
Quantum BioPharma Ltd. , a biopharmaceutical firm headquartered in Toronto, Canada, is dedicated to the discovery and advancement of biotechnological solutions and drug candidates. The company focuses on addressing complex neurodegenerative, inflammatory, and metabolic conditions, alongside alcohol use disorder, with its pipeline featuring a range of drug candidates at varying stages of development.
- CEO
- Zeeshan Saeed
- IPO
- 2018
- Employees
- 17
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on QNTM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $8.29M
- P/E
- -0.30
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.87
- EV/EBITDA
- -0.25
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -291.59%
- ROIC
- -6.90%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-15,302,374
- Net Income
- $-26,175,286-84.3%
- EPS
- $-8.11+35.1%
- OCF Growth
- -21.9%
- FCF Growth
- -21.9%
- 52W High
- $12.42
- 52W Low
- $1.26
- 50D MA
- $2.71
- 200D MA
- $3.61
- Beta
- 0.48
- RSI (14)
- 22
- Avg Volume
- 148.83K
No earnings-call transcripts are available for QNTM yet.
- Free Float
- 88.6%
- Shares Outstanding
- 6.43M
- Float Shares
- 5.69M
of shares held by institutions
27 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Advisorshares Investments LLC | 400.38K | ▲ 196.81K |
| Platform Technology Partners | 41.12K | 0 |
| Steward Partners Investment Advisory, LLC | 40.94K | ▲ 13.06K |
| Citadel Advisors LLC | 15.86K | 0 |
| Marex Group Ltd | 13.64K | ▲ 203 |
| Mariner, LLC | 10.00K | 0 |
| Lanark Financial, Inc. | 7.00K | 0 |
| Osaic Holdings, Inc. | 6.62K | ▲ 322 |
| Citigroup Inc | 5.85K | ▲ 5.85K |
| Atlantic Union Bankshares Corp | 2.00K | ▲ 1.00K |
| Jones Financial Companies Lllp | 1.21K | 0 |
| Royal Bank Of Canada | 685 | ▲ 239 |
Held by 1 ETFs
Biggest fund positions in QNTM by dollar value.
Our QNTM coverage
Recent articles, reports, and earnings notes.
No research on QNTM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate QNTM report →Quantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up
globenewswire.com · Nov 13
Quantum BioPharma Announces Results of Annual General and Special Meeting of Shareholders and Closing of Private Placement of Class A Multiple Voting Shares
globenewswire.com · Nov 11
Quantum BioPharma Ltd. Announces Filing of Supplement to Management Information Circular Correcting Fractional Share Treatment Under Proposed Share Consolidation and Clarifies MVS Voting Power Threshold
globenewswire.com · Nov 5
World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
globenewswire.com · Oct 8
Thermo Fisher Scientific (NYSE:TMO) Sets New 52-Week High – Time to Buy?
defenseworld.net · Oct 6
Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis
globenewswire.com · Oct 6
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
globenewswire.com · Sep 30
Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO
globenewswire.com · Sep 24
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.